Virus-like particles (VLPs) are multimeric nanostructures composed of one or more structural
proteins of a virus in the absence of genetic material. Having similar morphology to natural …

Ever since the development of the first vaccine, vaccination has had the great impact on
global health, leading to the decrease in the burden of numerous infectious diseases …

Flaviviruses such as dengue, yellow fever, Zika, West Nile, and Japanese encephalitis virus
present substantial global health burdens. New vaccines are being sought to address safety …

The SARS-CoV-2 pandemic has shown how a rapid rise in demand for patient and
community sample testing can quickly overwhelm testing capability globally. With most …

The emergence of the novel SARS-CoV-2 and COVID-19 has brought into sharp focus the
need for a vaccine to prevent this disease. Vaccines have saved millions of lives since their …

Dengue virus (DENV) is an emerging threat causing an estimated 390 million infections per
year. Dengvaxia, the only licensed vaccine, may not be adequately safe in young and …

Dengue virus (DENV) is the most common vector-borne viral disease, with nearly 400
million worldwide infections each year concentrated in the tropical and subtropical regions …

The Flaviviridae virus family was named after the Yellow-fever virus, and the latin term flavi
means “of golden color”. Dengue, caused by Dengue virus (DENV), is one of the most …

Dengue viruses (DENV) cause an estimated 390 million infections globally. With no dengue-
specific therapeutic treatment currently available, vaccination is the most promising strategy …

The emergence of Zika virus (ZIKV) in the Americas stimulated the development of multiple
ZIKV vaccine candidates. We previously developed two related DNA vaccine candidates …